Shire (NSDQ:SHPGY) said it agreed to acquire Pervasis Therapeutics and its endothelial cell technology for an undisclosed amount.
Tearlab Corp.
Syneron sees 250 percent jump in sales in 2010 | Earnings roundup
Syneron Medical Ltd. (NSDQ:ELOS) reported a 250 percent increase in sales during 2010, as the aesthetic device maker began to see some payoff from its 2009 acquisition of Candela Corp.
Syneron, a Yokneam, Israel aesthetic device company reported $189 million in sales during the year ending on Dec. 31, 2010, compared to $54 million for the same period last year. Much of that increase is directly attributed to products the company picked up in its $65 million acquisition of Candela Corp. in Sept. 2009.